Mechanism of action. Zoledronic acid slows down bone resorption, allowing the bone-forming cells time to rebuild normal bone and allowing bone remodeling.
Read about zoledronic acid (Reclast) a treatment for osteoporosis. Reclast is an injectable drug in the bisphosphonate drug class.
The primary objective: To demonstrate the non-inferiority of i.v. zoledronate 4 mg and/or 8 mg to Aredia 90 mg in preventing skeletal-related events (SREs) in ...
Medscape - Indication-specific dosing for Reclast, Zometa (zoledronate), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...
Have any studies evaluated the efficacy of zoledronate as treatment for primary osteoporosis?
Zoledronate (zoledronic acid, marketed by Novartis under the trade names Zometa and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in ...
Before receiving zoledronic acid injection, tell your doctor and pharmacist if you are allergic to zoledronic acid or any other medications, or any of the ...
Zoledronic acid can sometimes affect how your kidneys work. This doesn't usually cause any symptoms, and the effects are generally mild.
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Identification; Name: Zoledronate: Accession Number: DB00399 (APRD01294, DB06286) Type: Small Molecule: Groups: Approved: Description: Zoledronate (zoledronic acid ...